Vetter Pharma
Wouter Francois Willeman has extensive work experience in the pharmaceutical industry. Wouter Francois started their career at Johnson & Johnson as a Technical Specialist in Monoclonal Antibody Manufacturing from December 2001 to December 2003. Wouter Francois then joined Fresenius Kabi as the Head of Qualification & Validation and Project Leader for Contract Manufacturing Organization (CMO) from February 2005 to June 2007. After that, they worked at Ebewe Pharma as a Project Lead in CMC from June 2007 to December 2010. Wouter Francois then joined Vetter-Pharma Fertigung GmbH & Co. KG as a Customer Project Lead in CMO starting from January 2011. Currently, they are working at Patheon as a Project Lead in CMO since September 2016.
Wouter Francois Willeman completed their education in a chronological order as follows:
- From 1989 to 1993, Wouter attended Rotterdam University of Applied Sciences, where they obtained a B.Sc. in Chemical Engineering.
- In the following years, from 1993 to 1996, they pursued a Master of Science (M.Sc.) degree in Chemical Engineering at Delft University of Technology.
- Wouter then continued their education at Delft University of Technology from 1997 to 2001, where they completed a Ph.D. in Biotechnology.
It is worth noting that no information is available regarding any additional certifications or attended institution for Wouter.
This person is not in any offices
Vetter Pharma
2 followers
We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and biotechnology companies of all sizes, accompanying them on their journey to help those who are affected with their treatment of cancer, multiple sclerosis, and other diseases – from active ingredient development all the way to its delivery in people. With success comes responsibility. Teamwork, openness, and commitment: These qualities are important to us. At Vetter, we are sustainably helping to shape the future. We fully support personal and professional development – to build a strong team in which everyone can develop their skills, and in which every contribution counts. And for those who rely on us. Find out more about our company at www.vetter-pharma.com/ Privacy Notice: https://www.vetter-pharma.com/en/privacy-notice Imprint: https://www.vetter-pharma.com/en/imprint